Innate immune response to arenaviral infection: A focus on the highly pathogenic new world hemorrhagic arenaviruses

Journal of Molecular Biology

Volumn 425, Issue 24, 2013, Pages 4893-4903

  Koma, Takaaki ^a   Huang, Cheng ^a   Kolokoltsova, Olga A ^a   Brasier, Allan R ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

arenavirus; cytokine; innate immunity; interferon; interferon antagonist

Indexed keywords

ANTISERUM; CANDID 1 VACCINE; INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ARENAVIRUS; ARENAVIRUS INFECTION; ARGENTINE HEMORRHAGIC FEVER; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; NATURAL HOST; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS;

ARENAVIRIDAE; ARENAVIRUS; RNA VIRUSES;

EID: 84887994837     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.09.028     Document Type: Review

References (143)

1. M.J. Buchmeier, J.C. de la Torre, and C.J. Peters Arenaviridae: the viruses and their replication D.M. Knipe, H. PM, Fields virology 5th ed. 2 2007 Wolter Kluwer Lippincott Williams & Wilkins Philadelphia
2. R.N. Charrel, and X. de Lamballerie Arenaviruses other than Lassa virus Antiviral Res 57 2003 89 100
3. E.H. Stephenson, E.W. Larson, and J.W. Dominik Effect of environmental factors on aerosol-induced Lassa virus infection J Med Virol 14 1984 295 303
4. J.D. Rodas, I.S. Lukashevich, J.C. Zapata, C. Cairo, I. Tikhonov, and M. Djavani Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever J Med Virol 72 2004 424 435
5. S.K. Rai, B.K. Micales, M.S. Wu, D.S. Cheung, T.D. Pugh, and G.E. Lyons Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of mice Am J Pathol 151 1997 633 639
6. J. Ter Meulen, I. Lukashevich, K. Sidibe, A. Inapogui, M. Marx, and A. Dorlemann Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea Am J Trop Med Hyg 55 1996 661 666
7. R.N. Charrel, X. de Lamballerie, and S. Emonet Phylogeny of the genus Arenavirus Curr Opin Microbiol 11 2008 362 368
8. M.S. Salvato, J.C.S. Clegg, M.J. Buchmeier, R.N. Charrel, J.P. Gonzales, and I.S. Lukashevich Family Arenaviridae. Virus Taxonomy A.M.Q. King, M.J. Adams, E.B. Carstens, E.F. Lefkowitz, Ninth Report of the International Committee on Taxonomy of Viruses 2012 Elsevier Oxford
9. L.L. Barton Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen Clin Infect Dis 22 1996 197
10. L.L. Barton, and N.J. Hyndman Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen Pediatrics 105 2000 E35
11. T.M. Rivers, and T.F. McNair Scott Meningitis in man caused by a filterable virus Science 81 1935 439 440
12. T. Briese, J.T. Paweska, L.K. McMullan, S.K. Hutchison, C. Street, and G. Palacios Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa PLoS Pathog 5 2009 e1000455
13. J.D. Frame, J.M. Baldwin, D.J. Gocke, and J.M. Troup Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings Am J Trop Med Hyg 19 1970 670 676
14. S. Delgado, B.R. Erickson, R. Agudo, P.J. Blair, E. Vallejo, and C.G. Albarino Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia PLoS Pathog 4 2008 e1000047
15. J.I. Maiztegui, K.T. McKee, J.G. Barrera Oro, L.H. Harrison, P.H. Gibbs, and M.R. Feuillade Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group J Infect Dis 177 1998 277 283
16. J.B. McCormick, I.J. King, P.A. Webb, C.L. Scribner, R.B. Craven, and K.M. Johnson Lassa fever. Effective therapy with ribavirin N Engl J Med 314 1986 20 26
17. J.I. Maiztegui, N.J. Fernandez, and A.J. de Damilano Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome Lancet 2 1979 1216 1217
18. E. Vela Animal models, prophylaxis, and therapeutics for arenavirus infections Viruses 4 2012 1802 1829
19. E.C. Borden, and N. Nathanson Tacaribe virus infection of the mouse: an immunopathologic disease model Lab Invest 30 1974 465 473
20. J.A. Pedras-Vasconcelos, D. Goucher, M. Puig, L.H. Tonelli, V. Wang, and S. Ito CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus J Immunol 176 2006 4940 4949
21. J.F. Aronson, N.K. Herzog, and T.R. Jerrells Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs Am J Trop Med Hyg 52 1995 262 269
22. B.B. Gowen, D.F. Smee, M.H. Wong, J.O. Hall, K.H. Jung, and K.W. Bailey Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin PLoS One 3 2008 e3725
23. E.P. Scott, and J.F. Aronson Cytokine patterns in a comparative model of arenavirus haemorrhagic fever in guinea pigs J Gen Virol 89 2008 2569 2579
24. I.S. Lukashevich The search for animal models for Lassa fever vaccine development Expert Rev Vaccines 12 2013 71 86
25. O. Lenz, J. ter Meulen, H.D. Klenk, N.G. Seidah, and W. Garten The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P Proc Natl Acad Sci USA 98 2001 12701 12705
26. J.H. Nunberg, and J. York The curious case of arenavirus entry, and its inhibition Viruses 4 2012 83 101
27. S.S. Agnihothram, J. York, and J.H. Nunberg Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junin virus envelope glycoprotein complex J Virol 80 2006 5189 5198
28. S.R. Radoshitzky, J.H. Kuhn, C.F. Spiropoulou, C.G. Albarino, D.P. Nguyen, and J. Salazar-Bravo Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses Proc Natl Acad Sci USA 105 2008 2664 2669
29. M.L. Flanagan, J. Oldenburg, T. Reignier, N. Holt, G.A. Hamilton, and V.K. Martin New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1 J Virol 82 2008 938 948
30. S.R. Radoshitzky, J. Abraham, C.F. Spiropoulou, J.H. Kuhn, D. Nguyen, and W. Li Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses Nature 446 2007 92 96
31. G. Helguera, S. Jemielity, J. Abraham, S.M. Cordo, M.G. Martinez, and J.A. Rodriguez An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic fever arenaviruses J Virol 86 2012 4024 4028
32. J. Abraham, J.A. Kwong, C.G. Albarino, J.G. Lu, S.R. Radoshitzky, and J. Salazar-Bravo Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses PLoS Pathog 5 2009 e1000358
33. W. Cao, M.D. Henry, P. Borrow, H. Yamada, J.H. Elder, and E.V. Ravkov Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus Science 282 1998 2079 2081
34. C.F. Spiropoulou, S. Kunz, P.E. Rollin, K.P. Campbell, and M.B. Oldstone New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor J Virol 76 2002 5140 5146
35. C. Di Simone, M.A. Zandonatti, and M.J. Buchmeier Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike Virology 198 1994 455 465
36. C. Di Simone, and M.J. Buchmeier Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex Virology 209 1995 3 9
37. V. Castilla, S.E. Mersich, N.A. Candurra, and E.B. Damonte The entry of Junin virus into Vero cells Arch Virol 136 1994 363 374
38. P. Borrow, and M.B. Oldstone Mechanism of lymphocytic choriomeningitis virus entry into cells Virology 198 1994 1 9
39. G.A. Versteeg, and A. Garcia-Sastre Viral tricks to grid-lock the type I interferon system Curr Opin Microbiol 13 2010 508 516
40. M.S. Diamond, and M. Gale Cell-intrinsic innate immune control of West Nile virus infection Trends Immunol 33 2012 522 530
41. E.C. Borden, G.C. Sen, G. Uze, R.H. Silverman, R.M. Ransohoff, and G.R. Foster Interferons at age 50: past, current and future impact on biomedicine Nat Rev Drug Discov 6 2007 975 990
42. A.G. Bowie, and L. Unterholzner Viral evasion and subversion of pattern-recognition receptor signalling Nat Rev Immunol 8 2008 911 922
43. R. Medzhitov Recognition of microorganisms and activation of the immune response Nature 449 2007 819 826
44. K. Honda, H. Yanai, H. Negishi, M. Asagiri, M. Sato, and T. Mizutani IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 434 2005 772 777
45. Y.M. Loo, J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, and L. Martinez-Sobrido Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity J Virol 82 2008 335 345
46. O. Takeuchi, and S. Akira Innate immunity to virus infection Immunol Rev 227 2009 75 86
47. B. Beutler, C. Eidenschenk, K. Crozat, J.L. Imler, O. Takeuchi, and J.A. Hoffmann Genetic analysis of resistance to viral infection Nat Rev Immunol 7 2007 753 766
48. T. Fujita, K. Onoguchi, K. Onomoto, R. Hirai, and M. Yoneyama Triggering antiviral response by RIG-I-related RNA helicases Biochimie 89 2007 754 760
49. M. Yoneyama, and T. Fujita Structural mechanism of RNA recognition by the RIG-I-like receptors Immunity 29 2008 178 181
50. H. Kato, K. Takahasi, and T. Fujita RIG-I-like receptors: cytoplasmic sensors for non-self RNA Immunol Rev 243 2011 91 98
51. H. Kato, S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, and K. Matsui Cell type-specific involvement of RIG-I in antiviral response Immunity 23 2005 19 28
52. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, and M. Miyagishi The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat Immunol 5 2004 730 737
53. T. Kawai, K. Takahashi, S. Sato, C. Coban, H. Kumar, and H. Kato IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction Nat Immunol 6 2005 981 988
54. E.D. Tang, and C.Y. Wang MAVS self-association mediates antiviral innate immune signaling J Virol 83 2009 3420 3428
55. M. Baril, M.E. Racine, F. Penin, and D. Lamarre MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease J Virol 83 2009 1299 1311
56. K.A. Fitzgerald, S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, and D.T. Golenbock IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway Nat Immunol 4 2003 491 496
57. S. Sharma, B.R. tenOever, N. Grandvaux, G.P. Zhou, R. Lin, and J. Hiscott Triggering the interferon antiviral response through an IKK-related pathway Science 300 2003 1148 1151
58. K. Honda, and T. Taniguchi IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors Nat Rev Immunol 6 2006 644 658
59. K.W. Boehme, and T. Compton Innate sensing of viruses by toll-like receptors J Virol 78 2004 7867 7873
60. A.L. Blasius, and B. Beutler Intracellular toll-like receptors Immunity 32 2010 305 315
61. K. Bieback, E. Lien, I.M. Klagge, E. Avota, J. Schneider-Schaulies, and W.P. Duprex Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling J Virol 76 2002 8729 8736
62. E.A. Kurt-Jones, L. Popova, L. Kwinn, L.M. Haynes, L.P. Jones, and R.A. Tripp Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus Nat Immunol 1 2000 398 401
63. J.C. Rassa, J.L. Meyers, Y. Zhang, R. Kudaravalli, and S.R. Ross Murine retroviruses activate B cells via interaction with toll-like receptor 4 Proc Natl Acad Sci USA 99 2002 2281 2286
64. Z. Cao, J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel TRAF6 is a signal transducer for interleukin-1 Nature 383 1996 443 446
65. S. Li, A. Strelow, E.J. Fontana, and H. Wesche IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase Proc Natl Acad Sci USA 99 2002 5567 5572
66. H. Wesche, W.J. Henzel, W. Shillinglaw, S. Li, and Z. Cao MyD88: an adapter that recruits IRAK to the IL-1 receptor complex Immunity 7 1997 837 847
67. H. Sakurai, N. Shigemori, K. Hasegawa, and T. Sugita TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism Biochem Biophys Res Commun 243 1998 545 549
68. M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, and H. Sanjo Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 301 2003 640 643
69. K. Hoebe, X. Du, P. Georgel, E. Janssen, K. Tabeta, and S.O. Kim Identification of Lps2 as a key transducer of MyD88-independent TIR signalling Nature 424 2003 743 748
70. P.H. Tseng, A. Matsuzawa, W. Zhang, T. Mino, D.A. Vignali, and M. Karin Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines Nat Immunol 11 2010 70 75
71. N.A. de Weerd, S.A. Samarajiwa, and P.J. Hertzog Type I interferon receptors: biochemistry and biological functions J Biol Chem 282 2007 20053 20057
72. R.E. Randall, and S. Goodbourn Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures J Gen Virol 89 2008 1 47
73. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
74. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, and P. Bieniasz A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
75. N. Grandvaux, M.J. Servant, B. tenOever, G.C. Sen, S. Balachandran, and G.N. Barber Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes J Virol 76 2002 5532 5539
76. H.M. Lazear, A. Lancaster, C. Wilkins, M.S. Suthar, A. Huang, and S.C. Vick IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling PLoS Pathog 9 2013 e1003118
77. P. Borrow, L. Martinez-Sobrido, and J.C. de la Torre Inhibition of the type I interferon antiviral response during arenavirus infection Viruses 2 2010 2443 2480
78. T.C. Merigan, M.B. Oldstone, and R.M. Welsh Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice Nature 268 1977 67 68
79. R. Ou, S. Zhou, L. Huang, and D. Moskophidis Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells J Virol 75 2001 8407 8423
80. J.F. Bukowski, C.A. Biron, and R.M. Welsh Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus J Immunol 131 1983 991 996
81. M.F. Saron, Y. Riviere, A.G. Hovanessian, and J.C. Guillon Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus Virology 117 1982 253 256
82. E.B. Wilson, D.H. Yamada, H. Elsaesser, J. Herskovitz, J. Deng, and G. Cheng Blockade of chronic type I interferon signaling to control persistent LCMV infection Science 340 2013 202 207
83. G.A. Kolumam, S. Thomas, L.J. Thompson, J. Sprent, and K. Murali-Krishna Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection J Exp Med 202 2005 637 650
84. M.L. Milazzo, and C.F. Fulhorst Duration of Catarina virus infection in the southern plains woodrat (Neotoma micropus) Vector Borne Zoonotic Dis 12 2012 321 324
85. A.D. Vitullo, and M.S. Merani Vertical transmission of Junin virus in experimentally infected adult Calomys musculinus Intervirology 31 1990 339 344
86. A.D. Vitullo, V.L. Hodara, and M.S. Merani Effect of persistent infection with Junin virus on growth and reproduction of its natural reservoir, Calomys musculinus Am J Trop Med Hyg 37 1987 663 669
87. T.W. Geisbert, and P.B. Jahrling Exotic emerging viral diseases: progress and challenges Nat Med 10 2004 S110 S121
88. N.E. Yun, A.L. Poussard, A.V. Seregin, A.G. Walker, J.K. Smith, and J.F. Aronson Functional interferon system is required for clearance of lassa virus J Virol 86 2012 3389 3392
89. C.J. Peters, C.T. Liu, G.W. Anderson, J.C. Morrill, and P.B. Jahrling Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted Rev Infect Dis 11 1989 S743 S749
90. S. Baize, J. Kaplon, C. Faure, D. Pannetier, M.C. Georges-Courbot, and V. Deubel Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells J Immunol 172 2004 2861 2869
91. D.H. Walker, J.B. McCormick, K.M. Johnson, P.A. Webb, G. Komba-Kono, and L.H. Elliott Pathologic and virologic study of fatal Lassa fever in man Am J Pathol 107 1982 349 356
92. G.M. Edington, and H.A. White The pathology of Lassa fever Trans R Soc Trop Med Hyg 66 1972 381 389
93. S. Fisher-Hoch, J.B. McCormick, D. Sasso, and R.B. Craven Hematologic dysfunction in Lassa fever J Med Virol 26 1988 127 135
94. S. Baize, D. Pannetier, C. Faure, P. Marianneau, I. Marendat, and M.C. Georges-Courbot Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages Microbes Infect 8 2006 1194 1202
95. S. Mahanty, K. Hutchinson, S. Agarwal, M. McRae, P.E. Rollin, and B. Pulendran Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses J Immunol 170 2003 2797 2801
96. D. Pannetier, S. Reynard, M. Russier, A. Journeaux, N. Tordo, and V. Deubel Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus J Virol 85 2011 8293 8306
97. S. Baize, P. Marianneau, P. Loth, S. Reynard, A. Journeaux, and M. Chevallier Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys J Virol 83 2009 5890 5903
98. L.E. Hensley, M.A. Smith, J.B. Geisbert, E.A. Fritz, K.M. Daddario-DiCaprio, and T. Larsen Pathogenesis of Lassa fever in cynomolgus macaques Virol J 8 2011 205
99. R. Carrion, K. Brasky, K. Mansfield, C. Johnson, M. Gonzales, and A. Ticer Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues J Virol 81 2007 6482 6490
100. S.C. Levis, M.C. Saavedra, C. Ceccoli, E. Falcoff, M.R. Feuillade, and D.A. Enria Endogenous interferon in Argentine hemorrhagic fever J Infect Dis 149 1984 428 433
101. S.C. Levis, M.C. Saavedra, C. Ceccoli, M.R. Feuillade, D.A. Enria, and J.I. Maiztegui Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever J Interferon Res 5 1985 383 389
102. R.H. Kenyon, K.T. McKee, P.M. Zack, M.K. Rippy, A.P. Vogel, and C. York Aerosol infection of rhesus macaques with Junin virus Intervirology 33 1992 23 31
103. C.B. Dejean, B.L. Ayerra, and A.R. Teyssie Interferon response in the guinea pig infected with Junin virus J Med Virol 23 1987 83 91
104. G.D. Lerer, M.C. Saavedra, R. Falcoff, J.I. Maiztegui, and F.C. Molinas Activity of a platelet protein kinase that phosphorylates fibrinogen and histone in Argentine hemorrhagic fever Acta Physiol Pharmacol Ther Latinoam 41 1991 377 386
105. R.G. Pozner, A.E. Ure, C. Jaquenod de Giusti, L.P. D'Atri, J.E. Italiano, and O. Torres Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling PLoS Pathog 6 2010 e1000847
106. E.L. Stephen, S.K. Scott, G.A. Eddy, and H.B. Levy Effect of interferon on togavirus and arenavirus infections of animals Tex Rep Biol Med 35 1977 449 454
107. A. Grant, A. Seregin, C. Huang, O. Kolokoltsova, A. Brasier, and C. Peters Junin virus pathogenesis and virus replication Viruses 4 2012 2317 2339
108. O.A. Kolokoltsova, N.E. Yun, A.L. Poussard, J.K. Smith, J.N. Smith, and M. Salazar Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection J Virol 84 2010 13063 13067
109. B.B. Gowen, M.H. Wong, D. Larson, W. Ye, K.H. Jung, and E.J. Sefing Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog PLoS One 5 2010 e12760
110. J.A. Pedras-Vasconcelos, M. Puig, C. Sauder, C. Wolbert, M. Ovanesov, and D. Goucher Immunotherapy with CpG oligonucleotides and antibodies to TNF-alpha rescues neonatal mice from lethal arenavirus-induced meningoencephalitis J Immunol 180 2008 8231 8240
111. S.B. Bradfute, K.S. Stuthman, A.C. Shurtleff, and S. Bavari A STAT-1 knockout mouse model for Machupo virus pathogenesis Virol J 8 2011 300
112. N.E. Yun, A.V. Seregin, D.H. Walker, V.L. Popov, A.G. Walker, and J.N. Smith Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus J Virol 87 2013 10908 10911
113. J.F. Aronson, N.K. Herzog, and T.R. Jerrells Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains Am J Pathol 145 1994 228 235
114. A. Groseth, T. Hoenen, M. Weber, S. Wolff, A. Herwig, and A. Kaufmann Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages PLoS Negl Trop Dis 5 2011 e1137
115. A.M. Ambrosio, D.A. Enria, and J.I. Maiztegui Junin virus isolation from lympho-mononuclear cells of patients with Argentine hemorrhagic fever Intervirology 25 1986 97 102
116. M. Ambrosio, A. Vallejos, C. Saavedra, and J.I. Maiztegui Junin virus replication in peripheral blood mononuclear cells of patients with Argentine haemorrhagic fever Acta Virol 34 1990 58 63
117. P.H. Gonzalez, P.M. Cossio, R. Arana, J.I. Maiztegui, and R.P. Laguens Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features Arch Pathol Lab Med 104 1980 250 254
118. J.I. Maiztegui, R.P. Laguens, P.M. Cossio, M.B. Casanova, M.T. de la Vega, and V. Ritacco Ultrastructural and immunohistochemical studies in five cases of Argentine hemorrhagic fever J Infect Dis 132 1975 35 53
119. C.D. Cuevas, M. Lavanya, E. Wang, and S.R. Ross Junin virus infects mouse cells and induces innate immune responses J Virol 85 2011 11058 11068
120. S. Zhou, A. Halle, E.A. Kurt-Jones, A.M. Cerny, E. Porpiglia, and M. Rogers Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses J Neuroimmunol 194 2008 70 82
121. S. Zhou, E.A. Kurt-Jones, L. Mandell, A. Cerny, M. Chan, and D.T. Golenbock MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection Eur J Immunol 35 2005 822 830
122. C. Huang, O.A. Kolokoltsova, N.E. Yun, A.V. Seregin, A.L. Poussard, and A.G. Walker Junin virus infection activates the type I interferon pathway in a RIG-I-dependent manner PLoS Negl Trop Dis 6 2012 e1659
123. S. Zhou, A.M. Cerny, A. Zacharia, K.A. Fitzgerald, E.A. Kurt-Jones, and R.W. Finberg Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus J Virol 84 2010 9452 9462
124. S.M. Fennewald, J.F. Aronson, L. Zhang, and N.K. Herzog Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo J Virol 76 2002 1154 1162
125. G.C. Bowick, S.M. Fennewald, L. Zhang, X. Yang, J.F. Aronson, and R.E. Shope Attenuated and lethal variants of Pichinde virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics Viral Immunol 22 2009 457 462
126. G.C. Bowick, S.M. Fennewald, E.P. Scott, L. Zhang, B.L. Elsom, and J.F. Aronson Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics J Virol 81 2007 1923 1933
127. L. Martinez-Sobrido, S. Emonet, P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J.C. de la Torre Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus J Virol 83 2009 11330 11340
128. L. Martinez-Sobrido, P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J.C. de la Torre Differential inhibition of type I interferon induction by arenavirus nucleoproteins J Virol 81 2007 12696 12703
129. L. Martinez-Sobrido, E.I. Zuniga, D. Rosario, A. Garcia-Sastre, and J.C. de la Torre Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus J Virol 80 2006 9192 9199
130. K.M. Hastie, C.R. Kimberlin, M.A. Zandonatti, I.J. MacRae, and E.O. Saphire Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression Proc Natl Acad Sci USA 108 2011 2396 2401
131. X. Qi, S. Lan, W. Wang, L.M. Schelde, H. Dong, and G.D. Wallat Cap binding and immune evasion revealed by Lassa nucleoprotein structure Nature 468 2010 779 783
132. X. Carnec, S. Baize, S. Reynard, L. Diancourt, V. Caro, and N. Tordo Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages J Virol 85 2011 12093 12097
133. C. Pythoud, W.W. Rodrigo, G. Pasqual, S. Rothenberger, L. Martinez-Sobrido, and J.C. de la Torre Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon J Virol 86 2012 7728 7738
134. W.W. Rodrigo, E. Ortiz-Riano, C. Pythoud, S. Kunz, J.C. de la Torre, and L. Martinez-Sobrido Arenavirus nucleoproteins prevent activation of nuclear factor kappa B J Virol 86 2012 8185 8197
135. B. Harmon, C. Kozina, D. Maar, T.S. Carpenter, C.S. Branda, and O.A. Negrete Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for anti-interferon activity J Biol Chem 288 2013 8702 8711
136. L. Fan, T. Briese, and W.I. Lipkin Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction J Virol 84 2010 1785 1791
137. J.B. Marq, S. Hausmann, N. Veillard, D. Kolakofsky, and D. Garcin Short double-stranded RNAs with an overhanging 5′ ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys J Biol Chem 286 2011 6108 6116
138. J.B. Marq, D. Kolakofsky, and D. Garcin Unpaired 5′ ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I J Biol Chem 285 2010 18208 18216
139. D. Pannetier, C. Faure, M.C. Georges-Courbot, V. Deubel, and S. Baize Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection J Virol 78 2004 10516 10524
140. P.G. Canonico, M. Kende, B.J. Luscri, and J.W. Huggins In-vivo activity of antivirals against exotic RNA viral infections J Antimicrob Chemother 14 1984 27 41
141. R. Salomon, E. Hoffmann, and R.G. Webster Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection Proc Natl Acad Sci USA 104 2007 12479 12481
142. J. Chen, and K. Subbarao The immunobiology of SARS* Annu Rev Immunol 25 2007 443 472
143. K.J. Huang, I.J. Su, M. Theron, Y.C. Wu, S.K. Lai, and C.C. Liu An interferon-gamma-related cytokine storm in SARS patients J Med Virol 75 2005 185 194